“…Additionally, boys tend to respond less favorably to therapeutic efforts intended to improve pulmonary function antenatally, with administration of steroids (Ballard et al, 1980; Papageorgiou, Colle, Farri-Kostopoulos, & Gelfand, 1981), or postnatally, with administration of surfactant (Arnold, Adams, Torres, & Sidebottom, 1996; Corchia et al, 1997). In comparison with their female counterparts, boys have higher rates of cerebral palsy (Sizun et al, 1998; Spinillo et al, 1997), as well as ante-, peri-, and postnatal complications (for an overview, see Raz et al, 1994), such as preeclampsia (Brothwood, Wolke, Gamsu, Benson, & Cooper, 1986), certain types of intrauterine growth retardation (Spinillo et al, 1994), prematurity (Khoury et al, 1985), abruptio placenta and placenta previa (James, 1995), neonatal infections (Fanaroff et al, 1998), anemia, apnea and hypocalcemia (Brothwood et al, 1986), hypoglycemia (Corchia et al, 1997), intracranial hemorrhage (Amato, Howald, & von Muralt, 1987; Shankaran, Bauer, Bain, Wright, & Zachary, 1996), and meconium aspiration (Wiswell, Tuggle, & Turner, 1990). Boys are also at greater risk for developing neonatal respiratory distress than are girls of the same gestational age (Brothwood et al, 1986; Catlin et al, 1990; Torday, Nielson, Fencl, & Avery, 1981), and their odds of developing chronic lung disorders during the neonatal period are increased (Korhonen, Tammela, Koivisto, Laippala, & Ikonen, 1999; Todd, Jana, & John, 1997).…”